Gujarat-based Zydus Cadila has said that it was responding to a product-specific observation made by the United States Food and Drug... ...http://www.thehindubusinessline.com/companies/usfda-productrelated-review-zydus-says-no-business-impact/article6268615.ece?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS_Syndication
Motilal Oswal is bullish on Ranbaxy Labs and has recommended buy rating on the stock with a target of Rs 605 in its July 29, 2014 research report. ...http://www.moneycontrol.com/news/recommendations/buy-ranbaxy-labs-targetrs-605-motilal-oswal_1142152.html
By By | Reuters By Ben Hirschler LONDON (Reuters) - AstraZeneca raised its sales and earnings forecasts for the year on Thursday, showing... ...https://in.news.yahoo.com/astrazeneca-smashes-forecasts-q2-seeing-off-pfizer-064943874--finance.html
Sun Pharmaceutical Industries will be seeking shareholders approval for its $4 billion acquisition of Ranbaxy Laboratories in a court convened... ...http://www.indian-commodity.com/corporate/sun-pharma-to-seek-shareholders-approval-for-4-billion-acquisition-of-ranbaxy.aspx
Sudarshan Sukhani of s2analytics.com is of the view that one may see very large move on the upside in Ranbaxy Laboratories. ...http://www.moneycontrol.com/news/stocks-views/expect-upmoveranbaxy-sudarshan-sukhani_1142046.html
working in Ranbaxy
fadsf fdsfasdcv asdsf vasddfasd
The company was formed way back in...